An illustration of Flovent inhaler by GSK. — GSKIn 2024, users of the well-known corticosteroid inhalers Flovent HFA or Flovent Diskus will have to move to a new medicine to manage their asthma as GlaxoSmithKline , the company that makes them has decided to stop its production.According...from The News International - Health https://ift.tt/QrdovjW